Epidemiologic Risk Factors in a Comparison of a Barrett Esophagus Registry (BarrettNET) and a Case-Control Population in Germany.


Journal

Cancer prevention research (Philadelphia, Pa.)
ISSN: 1940-6215
Titre abrégé: Cancer Prev Res (Phila)
Pays: United States
ID NLM: 101479409

Informations de publication

Date de publication:
04 2020
Historique:
received: 17 10 2019
revised: 15 01 2020
accepted: 11 02 2020
pubmed: 19 2 2020
medline: 6 7 2021
entrez: 19 2 2020
Statut: ppublish

Résumé

Endoscopic screening for Barrett's esophagus as the major precursor lesion for esophageal adenocarcinoma is mostly offered to patients with symptoms of gastroesophageal reflux disease (GERD). However, other epidemiologic risk factors might affect the development of Barrett's esophagus and esophageal adenocarcinoma. Therefore, efforts to improve the efficiency of screening to find the Barrett's esophagus population "at risk" compared with the normal population are needed. In a cross-sectional analysis, we compared 587 patients with Barrett's esophagus from the multicenter German BarrettNET registry to 1976 healthy subjects from the population-based German KORA cohort, with and without GERD symptoms. Data on demographic and lifestyle factors, including age, gender, smoking, alcohol consumption, body mass index, physical activity, and symptoms were collected in a standardized epidemiologic survey. Increased age, male gender, smoking, heavy alcohol consumption, low physical activity, low health status, and GERD symptoms were significantly associated with Barrett's esophagus. Surprisingly, among patients stratified for GERD symptoms, these associations did not change. Demographic, lifestyle, and clinical factors as well as GERD symptoms were associated with Barrett's esophagus development in Germany, suggesting that a combination of risk factors could be useful in developing individualized screening efforts for patients with Barrett's esophagus and GERD in Germany.

Identifiants

pubmed: 32066580
pii: 1940-6207.CAPR-19-0474
doi: 10.1158/1940-6207.CAPR-19-0474
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

377-384

Informations de copyright

©2020 American Association for Cancer Research.

Auteurs

Melissa Schmidt (M)

Department of Medicine II, Klinikum rechts der Isar, Technical University Munich (TUM), München, Germany.

Donna P Ankerst (DP)

Department of Mathematics and Life Sciences, TUM, Boltzmannstr, Garching, Germany.

Yiyao Chen (Y)

Department of Mathematics and Life Sciences, TUM, Boltzmannstr, Garching, Germany.

Maria Wiethaler (M)

Department of Medicine II, Klinikum rechts der Isar, Technical University Munich (TUM), München, Germany.

Julia Slotta-Huspenina (J)

Institute of Pathology, TUM, München, Germany.
Tissue Bank of the Klinikum rechts der Isar Munich and TUM, Munich, Germany.

Karl-Friedrich Becker (KF)

Institute of Pathology, TUM, München, Germany.
Tissue Bank of the Klinikum rechts der Isar Munich and TUM, Munich, Germany.

Julia Horstmann (J)

Department of Medicine II, Klinikum rechts der Isar, Technical University Munich (TUM), München, Germany.

Florian Kohlmayer (F)

Institute of Medical Informatics, Statistics and Epidemiology, University Hospital rechts der Isar, TUM, Munich, Germany.

Andreas Lehmann (A)

Institute of Medical Informatics, Statistics and Epidemiology, University Hospital rechts der Isar, TUM, Munich, Germany.

Birgit Linkohr (B)

Institute of Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany.

Konstantin Strauch (K)

Institute of Genetic Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany.
Chair of Genetic Epidemiology, IBE, Faculty of Medicine, LMU Munich, Germany.

Roland M Schmid (RM)

Department of Medicine II, Klinikum rechts der Isar, Technical University Munich (TUM), München, Germany.

Anne S Quante (AS)

Institute of Genetic Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany.
Chair of Genetic Epidemiology, IBE, Faculty of Medicine, LMU Munich, Germany.
Department of Gynecology and Obstetrics, Klinikum rechts der Isar, TUM, Munich, Germany.

Michael Quante (M)

Department of Medicine II, Klinikum rechts der Isar, Technical University Munich (TUM), München, Germany. Michael.Quante@tum.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH